"Structure of a Bacterial ‘Drug Pump’ Reveals New Way to Counter Hospital-Borne Infection" Thanks NYU Langone Health for drafting a press release highlighting the importance of our work! Nate Traaseth Da-Neng Wang Check it out: nyulangone.org/news/structure…

Despite science’s recent triumphs, the biotech sector is surprisingly having one of its worst market runs in yrs ($XBI -19% YTD) Why? Raising interest rates; waning COVID allure; declining big pharma M&A. See all stats/reasons here👇 #biotech #investing wsj.com/articles/biote…

Rocky Mountains as an emerging biotech hub ... When can I move!? #boulder #colorado #biotech wsj.com/articles/black…

New patent alert! Dr. Marcus Weck of New York University’s Chemistry dept has developed new derivatives of a common #sunscreen photofilter, to maximize UV-A protection and better prevent against #skincancer & aging. patents.google.com/patent/US20210… #skinaging #uvdamage #sunscreen #dendrimers

Partnership opportunity! NYU Langone Health researchers have developed new antibodies against cancer target CD99 for the treatment of #leukemia & other blood malignancies -featuring nanomolar target affinity, high target selectivity, low toxicity, & IgG framework pubmed.ncbi.nlm.nih.gov/34958778/

Partnership opportunity! NYU Langone Health's michele pagano has ID'd new small molecule inhibitors of a key enzymatic complex in #coronaviruses to combat #SARSCoV2. The compounds, when combined w/ known drugs, show therapeutic potential as pan-coronavirus antivirals pubmed.ncbi.nlm.nih.gov/34862481/

A research team led by Dr. Ann Marie Schmidt at @NYULangone developed a new way to treat #diabetes-associated diseases w/ a #SmallMolecule inhibitor that blocks the RAGE protein's ability to pass on inflammatory signals that injure the heart and kidneys. nyulangone.org/news/experimen…

The Trabolsi Lab at NYU Abu Dhabi has developed novel organic #nanoparticles for oral #insulin delivery that could revolutionize #diabetes care! These nanoparticles can release insulin in a glucose-responsive manner to lower blood sugar levels. pubmed.ncbi.nlm.nih.gov/33995999/

TOV is excited to be a part of the 2022 BIO Convention this week in San Diego. We look forward to connecting with industry while representing some of NYU Langone Health’s and New York University’s impactful early-stage research. #therapeutics #drugdiscovery #biotech #techtransfer #BIO2022

📢NYU Langone Health innovators - A reminder that Therapeutics Alliances, NYU Langone's internal drug development accelerator, is currently seeking proposals for target discovery, target validation, and assay development projects. Application deadline is June 27 med.nyu.edu/research/techn…

What if you could apply sunscreen once in the morning and remain protected from the sun the entire day?New York University Chemistry Professor Marcus Weck and his lab are working to make that a reality. nyu.edu/about/news-pub…

Just announced! NYU Langone Health startup Canaery secured over $4M in seed funding to speed up development of its scent sensing platform. Langone Health participated in the funding round as an investor, making Canaery the 3rd investment from our new venture fund businesswire.com/news/home/2022…

Llamas to the rescue🦙! Check out this exciting nanobody technology for combatting #coronavirus infections from NYU Abu Dhabi that NYU Technology Opportunities & Ventures is looking to partner with industry for commercialization!

Great turnout for the first class in our fall course: Introduction to Biomedical Entrepreneurship - Foundations of Biomedical Startups! med.nyu.edu/research/techn…

The TOV team is at the #RESI conference in #Boston showcasing New York University's exciting portfolio of technologies and startups to #lifescience investors! If you are attending and would like to connect, please reach out.

New research from NYU Dentistry has found a topical gel treatment for gum disease. “No current treatment for gum disease simultaneously reduces inflammation, limits disruption to the oral microbiome, and prevents bone loss." nyu.edu/about/news-pub…

.NYU Langone Health's Kathryn Moore Lab developed a novel approach to suppress proinflammatory signals for the treatment of chronic inflammatory diseases! They ID'd the immune-augmenting role of the long noncoding RNA CHROMR and developed antisense oligonucleotides to block its function.

📢Norovirus Link to Crohn’s Disease May Point to New Therapies. nyulangone.org/news/norovirus… TOV is excited to help facilitate the commercialization of this innovative, early-stage therapeutic for the treatment of #CrohnsDisease from the Cadwell Lab and Dr. Shohei Koide’s group.

📢 Check out this innovative & game-changing biotechnology from NYU for generating a durable immune response against drug-resistant cancer cells! ⬇️

An engaging discussion at last night’s Biomed Entrepreneurship class! We were grateful to have Michal Gilon-Yanai from Two Lanterns Venture Partners & Joseph Ferino from Brown Rudnick who shared their knowledge/ perspectives on startup teams & the legal essentials of startups